28042065|t|Civil Society -Driven Drug Policy Reform for Health and Human Welfare - India
28042065|a|The lack of adequate access to opioids in India as analgesics and for agonist therapies, forces millions to live with severe unalleviated pain, or languish with suffering associated with drug dependence. Although India is a major opium exporter, the excessively prohibitive 1985 narcotics law formulated to control harmful use of drugs, impeded the availability and access to opioids for medical and scientific purposes. Amendment of this law in 2014 established a new national regulatory framework for improved access to essential opioid analgesics. This article reflects on key elements and processes that led to this landmark achievement. Unlike quick timelines associated with effecting policy reforms for law enforcement, realizing the 2014 drug policy change primarily to mitigate human suffering, was a 22-year-long process. The most exacting challenges included recognizing the multilayered complexities of the prior policy framework and understanding their adverse impact on field practices to chart an appropriate and viable path for reform. The evolution of an informal civil society movement involving health care professionals, lawyers, media, policy analysts, government officials, and the public was pivotal in addressing these challenges and garnering momentum for reform. The success of the effort for improving access to opioid medications was underpinned by a three-pronged strategy of 1) persuading the executive arm of the government to take interim enabling measures; 2) leveraging judicial intervention through public interest litigation; and 3) crafting a viable policy document for legislative approval and implementation. We hope our findings are useful for realizing drug policy reforms, given the current transformed global policy mandates emphasizing humanitarian, healthcare, and quality-of-life considerations.
28042065	0	13	Civil Society	UnknownType	C0680324
28042065	22	40	Drug Policy Reform	UnknownType	C0815220
28042065	45	51	Health	T078	C0018684
28042065	56	69	Human Welfare	T095	C0037440
28042065	72	77	India	T083	C0021201
28042065	82	86	lack	T080	C0332268
28042065	90	98	adequate	T080	C0205411
28042065	109	116	opioids	T109,T121,T131	C0242402
28042065	120	125	India	T083	C0021201
28042065	129	139	analgesics	T109,T121,T131	C0002771
28042065	148	155	agonist	T121	C2987634
28042065	156	165	therapies	T061	C0087111
28042065	196	202	severe	T080	C0205082
28042065	203	220	unalleviated pain	T184	C0030193
28042065	225	233	languish	T080	C1762617
28042065	239	248	suffering	T048	C0683278
28042065	265	280	drug dependence	T048	C1510472
28042065	291	296	India	T083	C0021201
28042065	308	313	opium	T109,T121	C0029112
28042065	314	322	exporter	T097	C0402574
28042065	340	351	prohibitive	T054	C0683610
28042065	357	370	narcotics law	T089	C0027413
28042065	385	392	control	T080	C0243148
28042065	393	413	harmful use of drugs	T048	C0013146
28042065	427	439	availability	T169	C0470187
28042065	444	450	access	T082	C0444454
28042065	454	461	opioids	T109,T121,T131	C0242402
28042065	466	473	medical	UnknownType	C0678312
28042065	478	488	scientific	T062	C0683933
28042065	489	497	purposes	T169	C1285529
28042065	499	508	Amendment	T170	C0680532
28042065	517	520	law	T170	C1947938
28042065	547	576	national regulatory framework	T089	C0220868
28042065	590	596	access	T082	C0444454
28042065	600	609	essential	T080	C0205224
28042065	610	627	opioid analgesics	T109,T121	C0002772
28042065	707	718	achievement	T053	C0001072
28042065	769	783	policy reforms	UnknownType	C0815220
28042065	788	803	law enforcement	T064	C0162469
28042065	824	835	drug policy	UnknownType	C0683727
28042065	856	864	mitigate	T067	C1553901
28042065	865	881	human suffering,	T048	C0683278
28042065	964	989	multilayered complexities	T033	C0037431
28042065	1003	1019	policy framework	T170	C0242456
28042065	1044	1051	adverse	T080	C0205169
28042065	1052	1058	impact	UnknownType	C0814716
28042065	1122	1128	reform	T064	C0206597
28042065	1159	1181	civil society movement	T054	C0680411
28042065	1192	1217	health care professionals	T097	C1704312
28042065	1219	1226	lawyers	T097	C0086530
28042065	1228	1233	media	T097	C4054555
28042065	1235	1250	policy analysts	T097	C0870132
28042065	1252	1272	government officials	T097	C0242304
28042065	1282	1288	public	T098	C0034035
28042065	1321	1331	challenges	T058	C0805586
28042065	1359	1365	reform	UnknownType	C0680438
28042065	1371	1378	success	T054	C0597535
28042065	1407	1413	access	T080	C0018748
28042065	1417	1423	opioid	T109,T121,T131	C0242402
28042065	1424	1435	medications	T058	C0150270
28042065	1501	1532	executive arm of the government	T097	C0335161
28042065	1541	1548	interim	T079	C2827738
28042065	1558	1566	measures	T170	C0033107
28042065	1582	1603	judicial intervention	T064	C0178362
28042065	1612	1618	public	T098	C0034035
28042065	1619	1627	interest	T098	C0021729
28042065	1628	1638	litigation	T068	C0079706
28042065	1647	1680	crafting a viable policy document	T064	C0242440
28042065	1685	1705	legislative approval	T064	C0680796
28042065	1710	1724	implementation	T052	C1708476
28042065	1772	1791	drug policy reforms	UnknownType	C0683727
28042065	1823	1829	global	T080	C2348867
28042065	1830	1836	policy	T170	C0242456
28042065	1837	1845	mandates	UnknownType	C0814715
28042065	1858	1870	humanitarian	T095	C0037440
28042065	1872	1882	healthcare	T058	C0086388
28042065	1888	1903	quality-of-life	T078	C0034380
28042065	1904	1918	considerations	T033	C0518609